tirzepatide shortage news october 2025 The Is Over: Here's What You Need to Know Lilly, Novo Fight Weight Loss

Protocol 2: significant weight loss (20-25% body weight) Goal: Substantial weight reduction for health improvement Tirzepatide approach: Full escalation to 10-15 mg Expect to reach target dose by week 17-21 Weight loss at 15 mg: approximately 22.5% at 72 weeks Plateau typically occurs around weeks 60-72 Retatrutide approach: Full escalation to 8-12 mg Expect to reach target dose by week 13-17 Weight loss at 12 mg: 24.2% at 48 weeks, 28.7% at 68 weeks No plateau observed in trial data at 48 or 68 weeks For significant weight loss goals, retatrutide reaches 20%+ body weight reduction faster and ultimately achieves a higher ceiling

Semaglutide tends to be preferred for patients prioritizing the lower-cost option, patients who want the longer real-world safety track record (semaglutide has been on the market longer), and patients with insurance coverage that favors Wegovy or Ozempic

A medical provider can help determine which option is most appropriate based on your goals and medical history

Take our quiz to find the perfect program for you